Bibliography

ACMD (2000), Reducing drug-related deaths. A Report by The Advisory Council on the Misuse of Drugs, The Stationery Office, London.

ACPO (2003), Cannabis enforcement guidance, ACPO, London.

Ashton, M. (2003), ‘The American STAR comes to England’, Drug and Alcohol Findings 8, pp. 21–6.

ASPECT Consortium (2004), Tobacco or Health in the European Union, Office for Official Publications of the European Communities, Luxembourg

Bandura, A. (1977), Social learning theory, Prentice-Hall, Englewood Cliffs, NJ.

Bargagli, A. M. et al. (2004), Drug-related mortality and its impact on adult mortality in eight European countries, 6th Europad Conference, Paris.

Becoña, E. (2002), Bases cientificas de la prevención de las drogodependencias, Delegación del Gobierno para el Plan Nacional sobre Drogas, Madrid.

Bird, S. and Rotily, M. (2002), ‘Inside methodologies for counting blood-borne viruses and injector-inmates’ behavioural risks – results from European prisons’, Howard Journal 41(2).

BKA (Bundeskriminalamt) (2004), Polizeiliche Kriminalstatistik 2003 Bundesrepublik Deutschland. BKA, Wiesbaden.

Blystad, H., Blad, L., Tulisov, A. and Aavitsland, P. (2005), ‘Hepatitis B in northwest Russia and the Nordic and Baltic countries: recent trends and prevention activities’, Eurosurveillance Weekly 10: 050310.

Botvin, G. J. (2000), ‘Preventing drug abuse in schools: social and competence enhancement approaches targeting individual-level etiological factors’, Addictive Behaviours 25, pp. 887–97.

Bovenkerk, F. and Hogewind, W. I. M. (2002), Hennepteelt in Nederland: het probleem van criminaliteit en haar bestrijding, Willem Pompe Instituut voor Strafrechtswetenschappen, Utrecht.

Brugal, M. T., Domingo-Salvany, A., Puig, R., et al. (2005), ‘Evaluating the impact of methadone maintenance programmes on mortality due to overdose and Aids in a cohort of heroin users in Spain’, Addiction, in press.

Butler, G. K. L. and Montgomery, A. M. J. (2004), ‘Impulsivity, risk taking and recreational “ecstasy” (MDMA) use’, Drug and Alcohol Dependence 76, pp. 55–62.

Butters, J. E. (2004), ‘The impact of peers and social disapproval on high-risk cannabis use: gender differences and implications for drug education’, Drugs: Education, Prevention and Policy 11, pp. 381–90.

Calafat, A., Fernández, C., Juan, M., et al. (2003), Enjoying the nightlife in Europe: the Role of moderation, IREFREA España, Palma de Mallorca.

Canning, U., Millward, L., Raj, T. and Warm, D. (2004), Drug use prevention among young people: a review of reviews, Health Development Agency, London.

CND (2004), World drug situation with regard to drug trafficking: report to the secretariat, Commission on Narcotic Drugs, United Nations Economic and Social Council, Vienna.

CND (2005), World drug situation with regard to drug trafficking: report to the secretariat, Commission on Narcotic Drugs, United Nations Economic and Social Council, Vienna.

Cuijpers, P., et al. (2002), ‘The effects of drug abuse prevention at school: the healthy school and drugs project’, Addiction 97, pp. 67–73.

Cunningham, J. A. (2001), ‘Impact of normative feedback on problem drinkers: a small-area population study’, Journal of Studies on Alcohol 62, pp. 228–33.

De Wit, A. and Bos, J. (2004), ‘Cost-effectiveness of needle and syringe exchange programmes: a review of the literature’, In Hepatitis C and injecting drug use: impact, costs and policy options, EMCDDA Monographs 7, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, pp. 329–43.

Drug Misuse Research Division (2004), ‘Trends in treated problem opiates use in the seven health board areas outside the Eastern Regional Health Authority, 1998 to 2002’, Occasional Paper No. 13/2004, Drug Misuse Research Division, Dublin.

EMCDDA (2001), ‘Co-ordination of the implementation of the EMCDDA standard guidelines on the drug-related deaths in the EU Member States, and the collection and analysis of information on drug-related deaths’, project CT.99.RTX.04, co-ordinated by the Trimbos Institute, European Monitoring Centre on Drugs and Drug Addiction, Lisbon.

EMCDDA (2003), ‘National prevalence estimates of problem drug use in the European Union, 1995–2000’, CT.00.RTX.23, coordinated by the Institut für Therapieforschung, Munich European Monitoring Centre on Drugs and Drug Addiction, Lisbon.

EMCDDA (2004a), Annual Report 2004: the state of the drugs problem in the European Union and Norway, European Monitoring Centre on Drugs and Drug Addiction, Lisbon.

EMCDDA (2004b), ‘Hepatitis C and injecting drug use: impact, costs and policy options’, EMCDDA Monographs 7, European Monitoring Centre for Drugs and Drug Addiction, Lisbon.

EMCDDA (2004c), Drugs in Focus 13. Overdose – a major cause of avoidable death among young people, European Monitoring Centre on Drugs and Drug Addiction, Lisbon.

Eurobarometer (2004), ‘Young people and drugs’, Flash Eurobarometer 158, Taylor Nelson Sofres, Directorate General Press and Communication, European Commission, Brussels.

EuroHIV (European Centre for the Epidemiological Monitoring of AIDS) (2004), HIV/AIDS Surveillance in Europe, End-year report, 2003, No. 70, Institut de Veille Sanitaire, Saint-Maurice.

Eurostat (2002), Health statistics: Key data on health 2002, Office for Official Publications of the European Communities, Luxembourg, p. 58.

Eysenbach, G., Powell, J., Englesakis, M., et al. (2004), ‘Health related virtual communities and electronic support groups: systematic review of the effects of online peer to peer interactions’, BMJ 328, p. 1166.

FSW (Fonds Soziales Wien) (2004), Jahresbericht 2003, Fonds Soziales Wien, Vienna.

Ghuran, A. and Nolan, J. (2000), ‘Recreational drug misuse: issues for the cardiologist’, Heart 83, pp. 627–33.

Gowing, L., Farrell, M., Bornemann, R. and Ali, R. (2005), ‘Substitution treatment of injecting opioid users for prevention of HIV infection’ (review), The Cochrane Library, 2005, Issue 2.

GLADA (Greater London Alcohol and Drug Allliance) (2004), An evidence base for London crack cocaine strategy, Greater London Alcohol and Drug Alliance, London

Haasen, C. (2003), Speech at ‘Conference on treatment monitoring in the EU and the EU action plan on drugs 2000–2004’ at the EMCDDA, November 2003.

Hawks, D., Scott, K., McBride, N., et al. (2002), Prevention of psychoactive substance use: a selected review of what works in the area of prevention, World Health Organization, Geneva.

Hibell, B., Andersson, B., Bjarnasson, T., et al. (2004), The ESPAD report 2003: alcohol and other drug use among students in 35 European Countries, The Swedish Council for Information on Alcohol and Other Drugs (CAN) and Council of Europe Pompidou Group.

Hwang, S. (2001), ‘Mental illness and mortality among homeless people’, Acta Psychiatrica Scandinavica 103, pp. 81–2.

INCB (2005), Report of the International Narcotics Control Board 2004, United Nations International Narcotics Control Board: New York.

Korkeila, J. (2000), Measuring aspects of mental health, Themes 6/2000, STAKES: Helsinki.

Kumpfer, K. L., Alvarado, R. and Whiteside, H. O. (2003), ‘Family-based interventions for substance use and misuse prevention’, Substance Use and Misuse 38, pp. 1759–87.

Leppin, A. (2004), Vortrag zur schulischen Suchtprävention im Rahmen der Fachtagung ’Qualität schulischer Suchtprävention’ am 20.04.04 in Kärnten.

Macchia, T., Giannotti, F. C. and Taggi, F. (2004), I servizi e le sostanze ricreazionali: una rilevazione clinica in Italia, FrancoAngeli, Milan.

Matheï, C., Robaeys, G., van Damme, P., et al. (2005), ‘Prevalence of hepatitis C in drug users in Flanders: determinants and geographic differences’, Epidemiology and Infection 133, pp. 127–36.

Mendes, F., Relvas, A. P., Olaio, A., et al. (2001), The challenge of prevention of drug use, IREFREA España, Palma de Mallorca.

Mol, A., Van Vlaanderen, J. L. and De Vos, A. (2002), Ontwikkeling van de cocaïne hulpvraag in de ambulante verslavingszorg 1994–2000, IVZ, Houten.

Morral, A. R., McCaffrey, D. F. and Paddock, S. M. (2002), ‘Reassessing the marijuana gateway effect’, Addiction 97, pp. 1493–504.

National Treatment Agency (NTA) (2003), ‘New guidance on injectable heroin and injectable methadone treatment for opiate misusers’, press statement 13 June 2003.

National Treatment Agency (NTA) (2004), ‘54 per cent more drug misusers get treatment in England’, press statement 30 September 2004.

Ouwehand, A., Van Alem, V., Mol, A. and Boonzajer Flaes, S. (2004), Key figures addiction care 2003, IVZ, Houten (http://www.sivz.nl).

Pijlman, F. T. A., Krul, J. and Niesink, R. J. M. (2003), Uitgaan en Veiligheid: Feiten en Fictie over Alcohol, Drugs en Gezondheidsverstoringen, Trimbos-instituut, Utrecht.

Prinzleve M., Haasen C., Zurhold H., et al. (2004), ‘Cocaine use in Europe – a multi-centre study: patterns of use in different groups’, European Addiction Research 10, pp. 147–55.

Quensel, S. (2004), Das Elend der Suchtprävention, Verlag für Sozialwissenschaften (VS), Wiesbaden.

Reis, J., Riley, W., Lokman, L. and Baer, J. (2000), ‘Interactive multimedia preventive alcohol education: a technology application in higher education’, Journal of Drug Education 30, pp. 399–421.

Reitox national reports (2004).

Rhodes, T., Lilly, R., Fernández, C., et al. (2003), ‘Risk factors associated with drug use: the importance of “risk environment”’, Drugs: Education, Prevention and Policy 10, pp. 303–29.

Rigter, H., Van Gageldonk, A., Ketelaars, T. and Van Laar, M. (2004), ‘Hulp bij probleemgebruik van drugs: stand van wetenschap voor behandelingen en andere interventies, 2004’, Trimbos Institute/National Drug Monitor (NDM), Utrecht.

SAMHSA, Office of Applied Studies, 2003 National Survey on Drug Use and Health.

Solberg, U., Burkhart, G. and Nilson, M. (2002), ‘An overview of opiate substitution treatment in the European Union and Norway’, International Journal of Drug Policy 13, pp. 477–84.

Sullivan, L. E., Metzger, D. S., Fudala, P. J. and Fiellin, D. A. (2005), ‘Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users’, Addiction 100, pp. 150–8.

Sussman, S., Earleywine, M., Wills, T., et al. (2004), ‘The motivation, skills and decision-making model of “drug abuse” prevention’, Substance Use and Misuse 39, pp. 1971–2016.

Taylor, B. J. (2000), ‘Modeling prevention program effects on growth in substance use: analysis of five years of data from the Adolescent Alcohol Prevention Trial’, Prevention Science 1, pp. 183–97.

Terweij, M. and Van Wamel, A. (2004), Ouders aan zet: opvoedingsondersteuning en verslavingspreventie voor allochtonen: succes- en faalfactoren, GGZ Nederland, Utrecht.

UNODC (2002), Contemporary drug abuse treatment: a review of the evidence base, United Nations Office on Drugs and Crime, Vienna.

UNODC (2003a), Global illicit drug trends 2003, United Nations Office on Drugs and Crime, Vienna.

UNODC (2003b), Ecstasy and amphetamines: global Survey 2003, United Nations Office on Drugs and Crime, Vienna.

UNODC and Government of Morocco (2003), Morocco cannabis survey 2003, United Nations Office on Drugs and Crime, Vienna.

WHO (1998), Opioid overdose: trends, risk factors, interventions and priorities for action, World Health Organization, Programme on Substance Abuse, Division of Mental Health and Prevention of Substance Abuse, Geneva.

WHO (2004), ‘Effectiveness of sterile needle and syringe programming in reducing HIV/AIDS among injecting drug users’, Evidence for action technical papers, WHO, Geneva.

WHO (2005), ‘Effectiveness of drug dependence treatment in preventing HIV among injecting drug users’, Evidence for action technical papers, final draft, March 2005, WHO, Geneva.

WHO Regional Office for Europe (2002), Prisons, drugs and society, a consensus statement on principles, policies and practices, WHO Regional Office for Europe, Geneva.